Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol

Atherosclerosis

Volumn 149, Issue 2, 2000, Pages 359-370

  Lin, Guorong ^a   Oram, John F ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; High density lipoproteins (HDL); Lipid free HDL

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E;

ARTICLE; CELL CULTURE; CELL STRUCTURE; CELL SURFACE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; SKIN FIBROBLAST; TANGIER DISEASE;

APOLIPOPROTEINS A; APOLIPOPROTEINS E; BINDING SITES; BIOLOGICAL TRANSPORT, ACTIVE; CELL MEMBRANE; CELLS, CULTURED; FIBROBLASTS; HUMANS; LIPOPROTEINS, HDL; MACROPHAGES; MICROSCOPY, IMMUNOELECTRON; SENSITIVITY AND SPECIFICITY; TANGIER DISEASE;

EID: 0034017526     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00503-1     Document Type: Article

References (59)

1. Miller G.J., Miller N.E. Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet. 1:1974;16-20.
2. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36:1995;211-228.
3. Oram J.F., Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid Res. 37:1996;2473-2491.
4. Phillips M.C., Gillotte K.L., Haynes M.P., Johnson W.J., Lund-Katz S., Rothblat G.H. Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes. Atherosclerosis. 137:1998;S13-S17.
5. Phillips M.C., Johnson W.J., Rothblat G.H. Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta. 906:1987;223-276.
6. Rothblat G.H., Mahlberg F.H., Johnson W.J., Phillips M.C. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J. Lipid Res. 33:1992;1091-1098.
7. Ji Y., Jian B., Wang N. et al. Scavenger receptor B1 promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272:1997;20982-20985.
8. Jian B., de la Llera Moya M., Ji Y. et al. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J. Biol. Chem. 273:1998;5599-5606.
9. Hara H., Yokoyama S. Interaction of free apolipoproteins with macrophages. J. Biol. Chem. 266:1991;3080-3086.
10. Bielicki J.K., Johnson W.J., Weinberg R.B., Glick J.M., Rothblat G.H. Efflux of lipid from fibroblasts to apolipoproteins: Dependence on elevated levels of cellular unesterified cholesterol. J. Lipid Res. 33:1992;1699-1709.
11. Forte T.M., Goth-Goldstein R., Nordhausen R.W., McCall M.R. Apolipoprotein A-I cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J. Lipid Res. 34:1993;317-324.
12. Yokoyama S. Apolipoprotein-mediated cellular cholesterol efflux. Biochim. Biophys. Acta. 1392:1998;1-15.
13. Mendez A.J., Anantharamaiah G.M., Oram J.F. Synthetic amphipathic helical peptides that stimulate clearance of cholesterol from cells. Circulation. 86:1992;2.
14. Savion N., Kotev-Emeth S. Role of apolipoproteins A-I, A-II and C-I in cholesterol efflux from endothelial and smooth muscle cells. Eur. Heart J. 14:1993;930-935.
15. Yancey P.G., Bielicki J.K., Johnson W.J. et al. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 34:1995;7955-7965.
16. Remaley A.T., Schumacher U.K., Stonik J.A., Farsi B.D., Nazih H., Brewer H.B. Decreased reverse cholesterol transport from Tangier disease fibroblasts: acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler. Thromb. Vasc. Biol. 17:1997;1813-1821.
17. Clay M.A., Newnham H.H., Forte T.M., Barter P.I. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim. Biophys. Acta. 1124:1992;52-58.
18. Liang H.Q., Rye K.A., Barter P.J. Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools. Biochim. Biophys. Acta. 1257:1995;31-37.
19. Tu A.Y., Nishida H.I., Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 268:1993;23098-23105.
20. von Eckardstein A., Jauhiainen M., Huang Y. et al. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre-beta-HDL. Biochim. Biophys. Acta. 1301:1996;255-262.
21. Oram J.F., Brinton E.A., Bierman E.L. Regulation of HDL receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells. J. Clin. Invest. 72:1983;1611-1621.
22. Savion N., Gamliel A. Binding of apolipoprotein A-I and apolipoprotein A-IV to cultured bovine aortic endothelial cells. Arteriosclerosis. 8:1988;178-186.
23. Mendez A.J., Oram J.F., Bierman E.L. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J. Biol. Chem. 266:1991;10104-10111.
24. Mollers C., Drobnik W., Resink T., Schmitz G. High-density lipoprotein and low-density lipoprotein-mediated signal transduction in cultured human skin fibroblasts. Cell Signal. 7:1995;695-707.
25. 3 stimulates multiple signaling pathways in human skin fibroblasts. Arterioscler. Thromb. Vasc. Biol. 15:1995;1975-1986.
26. Mendez A.J., Uint L. Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus. J. Lipid Res. 37:1996;2510-2524.
27. Mendez A.J., Oram J.F. Limited proteolysis of high density lipoprotein abolishes its interaction with cell-surface binding sites that promote cholesterol efflux. Biochim. Biophys. Acta. 1346:1997;285-299.
28. Serfaty-Lacroshiere C., Civeira F., Lanzberg A. et al. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis. 107:1994;85-98.
29. Assmann G.A., von Eckardstein A., Brewer H.B. Familial HDL deficiency: Tangier disease. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic Basis of Inherited Disease. 1995;2053-2072 McGraw-Hill Book, NY.
30. BrooksWilson A., Marcil M., Clee S.M. et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22:1999;336-345.
31. Bodzioch M., Orso E., Klucken J. et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22:1999;347-351.
32. Rust S., Rosier M., Funke H. et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22:1999;352-355.
33. Lawn RM, Wade DP, Garvin MR, et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway, J Clin Invest 1999.104:R25-R31.
34. Walter M., Gerdes U., Seedorf U., Assmann G. The high density lipoprotein apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects. Biochem. Biophys. Res. Commun. 205:1994;850-856.
35. Francis G.A., Knopp R.H., Oram J.F. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J. Clin. Invest. 96:1995;78-87.
36. Rall S.C., Weisgraber K.H., Makley R.W. Isolation and characterization of apolipoprotein E. Methods Enzymol. 128:1986;273-281.
37. Mendez A.J., Anantharamaiah G.M., Segrest J.P., Oram J.F. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J. Clin. Invest. 94:1994;1698-1705.
38. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediate uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76:1979;333-337.
39. Auwerx J.H., Deeb S.S., Brunzell J.D., Chait A. Transcriptional regulation of lipoprotein lipase during macrophage differentiation. Arterioscler. Thromb. 8:1988;567AS. Abstract.
40. Garrigues H.J., Lark M.W., Lara S., Hellstrom I., Hellstrom K.E., Wight T.N. The melanoma proteoglycan: restricted expression on microspikes, a specific microdomain of the cell surface. J. Cell Biol. 103:1986;1699-1710.
41. Smith J.D., Miyata M., Ginsberg M,. Grigaux C., Shmookler E., Plump A.S. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J. Biol. Chem. 271:1996;30647-30655.
42. Mendez A.J. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J. Lipid Res. 38:1997;1807-1821.
43. Oram J.F., Johnson C.J., Brown T.A. Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages: evidence for reversible binding at the cell surface without internalization. J. Biol. Chem. 262:1987;2405-2410.
44. Schmitz G., Niemann R., Brennhausen B., Krauss R.M., Assmann G. Regulation of high density lipoprotein receptors in cultured macrophages: role of acyl CoA:cholesterol acyltransferase. EMBO J. 4:1985;2773-2779.
45. Jonas A., Steinmetz A., Churgay L. The number of amphipathic α-helical segments of apolipoproteins A-I, E, and A-IV determines the size and functional properties of their reconstituted lipoprotein particles. J. Biol. Chem. 268:1993;1596-1602.
46. Huang Y., Eckardstein A., Wu S., Maeda N., Assmann G. A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. Proc. Natl. Acad. Sci. USA. 91:1994;1834-1838.
47. Herscovitz H., Gantz D., Tercyak A.M., Zannis V.I., Small D.M. Expression of human apolipoprotein E but not that of apolipoprotein A-I by mouse C127 cells is associated with increased secretion of lipids in the form of vesicles and discs. J. Lipid Res. 33:1992;791-803.
48. Kruth H.S., Skarlatos S.I., Gaynor P.M., Gamble W. Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux. J. Biol. Chem. 269:1994;24511-24518.
49. Asztalos B., Zhang W., Roheim P.S., Wong L. Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles. Arterioscler. Thromb. Vasc. Biol. 17:1997;1630-1636.
50. Rigotti A., Trigatti B.L., Penman M., Rayburn H., Herz J., Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. USA. 94:1997;12610-12615.
51. Xu S., Laccotripe M., Huang X., Rigotti A., Zannis V.I., Krieger M. Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake. J. Lipid Res. 38:1997;1289-1298.
52. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:1986;34-47.
53. Fielding C.J., Fielding P.E. Intracellular cholesterol transport. J. Lipid Res. 38:1997;1503-1521.
54. Babitt J., Trigatti B., Rigotti A., Anderson R.G.W., Xu S.Z., Krieger M. Murine SR-Bl, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J. Biol. Chem. 272:1997;13242-13249.
55. Lin G., Oram J., O'Brien K. Cellular localization of apolipoproteins in human atherosclerotic lesions. J. Invest. Med. 47:1999;53A.
56. Gillotte K.L., Davidson W.S., Lund-Katz S., Rothblat G.H., Phillips M.C. Removal of cellular cholesterol by pre-β-HDL involves plasma membrane in microsolubilization. J. Lipid Res. 39:1998;1918-1928.
57. Gillotte K.L., Zaiou M., Lund-Katz S. et al. Apolipoprotein-mediated plasma membrane microsolubilization: role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid. J. Biol. Chem. 274:1999;2021-2028.
58. Asztalos B.F., Roheim P.S. Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma. Arterioscler. Thromb. Vasc. Biol. 15:1995;1419-1423.
59. Wong L., Sivok B., Kurucz E., Sloop C.H., Roheim P.S., Asztalos B. Lipid composition of HDL subfractions in dog plasma and lymph. Arterioscler. Thromb. Vasc. Biol. 15:1995;1875-1881.